“The development tumor model” to study and monitor the entire progression of both primary and metastatic tumors

ISSN： 1010-4283

Source： Tumor Biology, Vol.35, Iss.3, 2014-03, pp. : 2219-2230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer

Oncology Reports, Vol. 34, Iss. 6, 2015-01 ,pp. : 2837-2844

Spandidos Publications

Access to resources Recommend Favorite

Netrin-4 overexpression suppresses primary and metastatic colorectal tumor progression

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 73-78

Spandidos Publications

Access to resources Recommend Favorite

Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer

By Delpech Y.

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 619-627

Springer Publishing Company

Access to resources Recommend Favorite

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

By Méndez Romero Alejandra Wunderink Wouter Hussain Shahid De Pooter Jacco Heijmen Ben Nowak Peter Nuyttens Joost Brandwijk Rene Verhoef Cees Ijzermans Jan Levendag Peter

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 831-837

Informa Healthcare

Access to resources Recommend Favorite

Role of nitric oxide in tumor progression: Lessons from experimental tumors

By Lala P.K.

Cancer and Metastasis Reviews, Vol. 17, Iss. 1, 1998-03 ,pp. : 91-106

Springer Publishing Company

Access to resources Recommend Favorite